Entity Type
Company
SEC filings, ownership reports, and insider transactions for CIK 0001768564.
Entity Type
Company
Total Filings
41
Latest Filing
01 Apr 2026
Industry
n/a
Save this filer for return loops, then jump into the latest filing evidence.
Save this research page
Create a free account to save this filer and follow future SEC filing updates.
New Enterprise Associates 17, L.P. has filed 41 SEC EDGAR filings since 01 Mar 2019. Common forms include SCHEDULE 13D/A, 4, SCHEDULE 13D, 3 and more.
Recent SEC filings for New Enterprise Associates 17, L.P. with direct links to document and filing folders.
| Form type | Document | Filing | Description | Filing date | Reporting date | File number(s) |
|---|---|---|---|---|---|---|
| SCHEDULE 13D/A | Open SCHEDULE 13D/A document | View SEC filing for SCHEDULE 13D/A | 01 Apr 2026 | |||
| SCHEDULE 13D/A | Open SCHEDULE 13D/A document | View SEC filing for SCHEDULE 13D/A | 19 Mar 2026 | |||
| 4 | Open 4 document | View SEC filing for 4 | 4 | 12 Mar 2026 | 10 Mar 2026 | 001-39062 |
| SCHEDULE 13D/A | Open SCHEDULE 13D/A document | View SEC filing for SCHEDULE 13D/A | 12 Mar 2026 | |||
| SCHEDULE 13D | Open SCHEDULE 13D document | View SEC filing for SCHEDULE 13D | 13 Feb 2026 | |||
| 4 | Open 4 document | View SEC filing for 4 | 4 | 11 Feb 2026 | 09 Feb 2026 | 001-43105 |
| 3 | Open 3 document | View SEC filing for 3 | 3 | 05 Feb 2026 | 05 Feb 2026 | 001-43105 |
| SCHEDULE 13D/A | Open SCHEDULE 13D/A document | View SEC filing for SCHEDULE 13D/A | 10 Nov 2025 | |||
| SCHEDULE 13D/A | Open SCHEDULE 13D/A document | View SEC filing for SCHEDULE 13D/A | 06 Oct 2025 | |||
| 4 | Open 4 document | View SEC filing for 4 | 4 | 06 Oct 2025 | 02 Oct 2025 | 001-40537 |
| SCHEDULE 13D/A | Open SCHEDULE 13D/A document | Open XBRL data | View SEC filing for SCHEDULE 13D/A | 07 May 2025 | |||
| SCHEDULE 13D/A | Open SCHEDULE 13D/A document | Open XBRL data | View SEC filing for SCHEDULE 13D/A | 26 Dec 2024 | |||
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | NEW ENTERPRISE ASSOCIATES 17, L.P. -- INVENTIVA S.A. 13D/A(#2) | 21 Oct 2024 | ||
| 4 | Open 4 document | View SEC filing for 4 | 4 | 03 Oct 2024 | 01 Oct 2024 | 001-40537 |
| SC 13D | Open SC 13D document | View SEC filing for SC 13D | NEW ENTERPRISE ASSOCIATES 17, L.P. -- MBX BIOSCIENCES, INC. 13D | 23 Sep 2024 | ||
| 4 | Open 4 document | View SEC filing for 4 | 4 | 17 Sep 2024 | 16 Sep 2024 | 001-42272 |
| 3 | Open 3 document | View SEC filing for 3 | 3 | 12 Sep 2024 | 12 Sep 2024 | 001-42272 |
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | NEW ENTERPRISE ASSOCIATES 17, L.P. -- MONTE ROSA THERAPEUTICS 13D/A(#2) | 12 Aug 2024 | ||
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | NEW ENTERPRISE ASSOCIATES 17, L.P. -- MONTE ROSA THERAPEUTICS 13D/A(#1) | 13 May 2024 | ||
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | NEW ENTERPRISE ASSOCIATES 17, L.P. -- INVENTIVA S.A. 13D/A(#1) | 03 May 2024 | ||
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | NEW ENTERPRISE ASSOCIATES 17, L.P. -- KORRO BIO, INC. 13D/A(#1) | 24 Apr 2024 | ||
| 4 | Open 4 document | View SEC filing for 4 | 4 | 24 Apr 2024 | 22 Apr 2024 | 001-39062 |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 10 Apr 2024 | 08 Apr 2024 | 001-40537 |
| SC 13D | Open SC 13D document | View SEC filing for SC 13D | NEW ENTERPRISE ASSOCIATES 17, L.P. -- KORRO BIO, INC. 13D | 17 Nov 2023 | ||
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 07 Nov 2023 | 03 Nov 2023 | 001-39062 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 19 Jul 2023 | 17 Jul 2023 | 001-32157 |
| 3/A | Open 3/A document | View SEC filing for 3/A | FORM 3/A SUBMISSION | 20 Oct 2022 | 17 Oct 2022 | 001-40537 |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 19 Oct 2022 | 17 Oct 2022 | 001-40537 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 04 May 2022 | 02 May 2022 | 001-40691 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 01 Feb 2022 | 28 Jan 2022 | 001-40691 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 12 Nov 2021 | 10 Nov 2021 | 001-40691 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 29 Oct 2021 | 27 Oct 2021 | 001-40691 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 03 Aug 2021 | 02 Aug 2021 | 001-40691 |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 29 Jul 2021 | 29 Jul 2021 | 001-40691 |
| SC 13D | Open SC 13D document | View SEC filing for SC 13D | NEW ENTERPRISE ASSOCIATES 17, L.P. / BRIGHT HEALTH GROUP, INC. -- SCHEDULE 13D | 26 Jul 2021 | ||
| SC 13D | Open SC 13D document | View SEC filing for SC 13D | NEW ENTERPRISE ASSOCIATES 17, L.P. / MONTE ROSA THERAPEUTICS, INC. -- SCHEDULE 1 | 12 Jul 2021 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 30 Jun 2021 | 28 Jun 2021 | 001-40522 |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 23 Jun 2021 | 23 Jun 2021 | 001-40522 |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 16 Mar 2021 | 15 Mar 2021 | 001-32157 |
| SC 13D | Open SC 13D document | View SEC filing for SC 13D | NEW ENTERPRISE ASSOCIATES 17, L.P. / INVENTIVA S.A. -- SCHEDULE 13D | 21 Jul 2020 | ||
| D | Open D document | View SEC filing for D | 01 Mar 2019 | 021-333845 |
New Enterprise Associates 17, L.P. files with the SEC under CIK 0001768564. This page aggregates EDGAR filings and related ownership activity.